Ambit Biosciences is looking to make an impact on Acute Myloid Leukemia using a targeted strategy to replace non-specific, decades old therapies currently in use.
http://seekingalpha.com/article/1575642-ambit-bridging-multi-decade-gap-in-fight-against-aml-other-disease-targets-to-follow?source=feed
http://seekingalpha.com/article/1575642-ambit-bridging-multi-decade-gap-in-fight-against-aml-other-disease-targets-to-follow?source=feed
No comments:
Post a Comment